FindTrial
Sign In

Personalized Neoantigen Peptide vaccine

BIOLOGICAL2 trials

Sponsors

Seqker Biosciences, Inc., Chulalongkorn University

Conditions

Advanced CancerNeoantigen-Specific ImmunotherapyPersonalized Cancer VaccineRecurrent CancerSolid Tumorsadvanced-stage melanoma, advanced-stage renal cell carcinoma Neoantigen peptide vaccine, Immunotherapy, Metastatic cancer

Phase 1

Phase Ib Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma
Active, not recruitingTCTR20191003001
Chulalongkorn Universityadvanced-stage melanoma, advanced-stage renal cell carcinoma Neoantigen peptide vaccine, Immunotherapy, Metastatic cancer
Start: 2021-01-01Target: 12Updated: 2026-08-03
Personalized Neoantigen Peptide Vaccines for Solid Tumors
RecruitingNCT07002203
Seqker Biosciences, Inc.Advanced Cancer, Neoantigen-Specific Immunotherapy, Personalized Cancer Vaccine +2
Start: 2024-03-01End: 2027-08-01Target: 10Updated: 2026-07-24